Physician profile
Bryan Wayne Hager
NPI 1053692426
$3,673.03
in general payments reported to CMS, 2019-2025
29 companies · $82.98 in 2025
The $82.98 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $767 · 2022: $946 · 2023: $1,116 · 2024: $760 · 2025: $82.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,959.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $269.49 | 2021-2024 | Jardiance |
| Edwards Lifesciences Corporation | $266.37 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Merck Sharp & Dohme LLC | $258.12 | 2021-2024 | Verquvo |
| Novartis Pharmaceuticals Corporation | $248.00 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $243.83 | 2021-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $224.54 | 2021-2023 | |
| Esperion Therapeutics, INC. | $221.33 | 2021-2024 | Nexletol |
| Amgen INC. | $206.27 | 2021-2024 | Repatha |
| Abbott Laboratories | $195.78 | 2021-2022 | |
| Heartflow, INC. | $156.08 | 2022-2025 | Ffrct |
| Pfizer INC. | $154.35 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $153.91 | 2021-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $150.11 | 2021-2024 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $148.77 | 2021-2024 | Andexxa, Farxiga |
| Cvrx, INC. | $103.58 | 2023 | Barostim Neo System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $86.11 | 2023 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $80.88 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $65.33 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $56.36 | 2023 | Onpattro |
| Amarin Pharma, INC. | $55.00 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $50.83 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $46.69 | 2022 | |
| Novo Nordisk INC | $42.89 | 2024 | Ozempic, Rybelsus |
| Boston Scientific Corporation | $42.55 | 2021-2023 | Watchman Access System |
| Kowa Pharmaceuticals America, INC. | $37.41 | 2021 | |
| Arbor Pharmaceuticals, INC. | $35.55 | 2021-2022 | |
| Philips North America LLC | $29.32 | 2022 | |
| Abiomed | $29.09 | 2024 | Impella |
| Lexicon Pharmaceuticals, INC. | $14.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Hager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.